Serum soluble Fas ligand is a severity and mortality prognostic marker for COVID-19 patients

被引:14
|
作者
Saleki, Kiarash [1 ,2 ,3 ,4 ]
Shirzad, Moein [1 ,2 ,4 ]
Javanian, Mostafa [5 ]
Mohammadkhani, Sheyda [2 ]
Alijani, Mohammad Hossein [2 ]
Miri, Niloufarsadat [1 ]
Oladnabi, Morteza [6 ]
Azadmehr, Abbas [1 ,4 ,7 ]
机构
[1] Babol Univ Med Sci, Hlth Res Inst, Cellular & Mol Biol Res Ctr, Babol, Iran
[2] Babol Univ Med Sci, Student Res Comm, Babol, Iran
[3] Babol Univ Med Sci, USERN Off, Babol, Iran
[4] Natl Elite Fdn, Mazandaran Prov Branch, Mazandaran, Iran
[5] Babol Univ Med Sci, Hlth Res Inst, Infect Dis & Trop Med Res Ctr, Babol, Iran
[6] Golestan Univ Med Sci, Ischem Disorders Res Ctr, Gorgan, Iran
[7] Babol Univ Med Sci, Immunol Dept, Babol, Iran
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词
COVID-19; hyperinflammation; Fas; viral Immunology; immunoinformatics; AA FORCE-FIELD; EXPRESSION; APOPTOSIS; INJURY; ACTIVATION; VIRUS; GENE;
D O I
10.3389/fimmu.2022.947401
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Finding cytokine storm initiator factors associated with uncontrolled inflammatory immune response is necessary in COVID-19 patients. The aim was the identification of Fas/Fas Ligand (FasL) role in lung involvement and mortality of COVID-19 patients. In this case-control study, mild (outpatient), moderate (hospitalized), and severe (ICU) COVID-19 patients and healthy subjects were investigated. RNA isolated from PBMCs for cDNA synthesis and expression of mFas/mFasL mRNA was evaluated by RT-PCR. Serum sFas/sFasL protein by ELISA and severity of lung involvement by CT-scan were evaluated. Also, we docked Fas and FasL via Bioinformatics software (in silico) to predict the best-fit Fas/FasL complex and performed molecular dynamics simulation (MDS) in hyponatremia and fever (COVID-19 patients), and healthy conditions. mFasL expression was increased in moderate and severe COVID-19 patients compared to the control group. Moreover, mFas expression showed an inverse correlation with myalgia symptom in COVID-19 patients. Elevation of sFasL protein in serum was associated with reduced lung injury and mortality. Bioinformatics analysis confirmed that blood profile alterations of COVID-19 patients, such as fever and hyponatremia could affect Fas/FasL complex interactions. Our translational findings showed that decreased sFasL is associated with lung involvement; severity and mortality in COVID-19 patients. We think that sFasL is a mediator of neutrophilia and lymphopenia in COVID-19. However, additional investigation is suggested. This is the first report describing that the serum sFasL protein is a severity and mortality prognostic marker for the clinical management of COVID-19 patients.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Prognostic Value of Serum MICA Levels as a Marker of Severity in COVID-19 Patients
    Farzad, Faramarz
    Yaghoubi, Neda
    Jabbari-Azad, Farahzad
    Mahmoudi, Mahmoud
    Mohammadi, Mojgan
    IMMUNOLOGICAL INVESTIGATIONS, 2022, 51 (06) : 1856 - 1866
  • [2] Prognostic Significance of Soluble Fas and Soluble Fas Ligand in Serum of Patients with Complete Hydatidiform Moles
    Soni, Simmi
    Rath, Gayatri
    Deval, Ravi
    Salhan, Sudha
    Mishra, Ashwini Kumar
    Saxena, Sunita
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2011, 66 (03) : 230 - 236
  • [3] Prognostic significance of a combination of soluble Fas and soluble Fas ligand in the serum of patients with Ta bladder cancer
    Mizutani, Y
    Yoshida, O
    Ukimura, O
    Kawauchi, A
    Bonavida, B
    Miki, T
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2002, 17 (05) : 563 - 567
  • [4] Prognostic factors for predicting severity and mortality in hospitalized COVID-19 patients
    Aljohani, Fahad Dakilallah
    Khattab, Amin
    Elbadawy, Hossein M.
    Alhaddad, Aisha
    Alahmadey, Ziab
    Alahmadi, Yaser
    Eltahir, Heba M.
    Matar, Heba M. H.
    Wanas, Hanaa
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (03)
  • [5] Prognostic significance of serum soluble Fas ligand in patients with bladder cancer
    Mizutani, Y
    Hongo, F
    Nomoto, T
    Kawauchi, A
    Nakao, M
    Nakanishi, H
    Sato, N
    Miki, T
    JOURNAL OF UROLOGY, 2002, 167 (04): : 120 - 120
  • [6] Glucose variability is a marker for COVID-19 severity and mortality
    Abuhasira, Ran
    Grossman, Alon
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2022, 66 (06): : 856 - 862
  • [7] Leptin as a potential prognostic marker of the severity of COVID-19 infection in obese patients
    Baltodano-Calle, Maria J.
    Polo-Vasquez, Jhoanna S.
    Romani-Pozo, Alina
    Gutarra-Saldana, Diego
    Guija-Poma, Emilio
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2022, 32 (03) : 743 - 744
  • [8] A Prognostic Marker in COVID-19 Disease Severity and Mortality: D-Dimer/Platelet Ratio
    Tahmaz, Alper
    Keskin, Aysegul Seremet
    Kizilates, Filiz
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [9] Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review
    Izcovich, Ariel
    Alberto Ragusa, Martin
    Tortosa, Fernando
    Lavena Marzio, Maria Andrea
    Agnoletti, Camila
    Bengolea, Agustin
    Ceirano, Agustina
    Espinosa, Federico
    Saavedra, Ezequiel
    Sanguine, Veronica
    Tassara, Alfredo
    Cid, Candelaria
    Norberto Catalano, Hugo
    Agarwal, Arnav
    Foroutan, Farid
    Rada, Gabriel
    PLOS ONE, 2020, 15 (11):
  • [10] Sysmex-derived COVID-19 prognostic score as an early prognostic marker for severity of the COVID-19 disease
    Blazek, Martin
    Vrbacky, Filip
    Fatorova, Ilona
    Mirska, Klara
    Zak, Pavel
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 (02) : 243 - 249